3,775 results on '"Fava, Maurizio"'
Search Results
402. Combined MI + CBT for Depressive Symptoms and Binge Drinking Among Young Adults: Two Case Studies
403. The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists
404. Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression
405. Psychopharmacology in the Medical Setting
406. Severe Depression: Is There a Best Approach?
407. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
408. Epidemiologic Evidence Concerning the Bereavement Exclusion in Major Depression
409. Tryptophan depletion in SSRI-recovered depressed outpatients
410. Contributing Authors
411. Mood-Disordered Patients
412. Suppression and acceptance in unipolar depression: Short‐term and long‐term effects on emotional responding.
413. Somatic Symptoms in Outpatients With Major Depressive Disorder Treated With Fluoxetine
414. Management of depression relapse: Re-initiation of duloxetine treatment or dose increase
415. Adjunctive atomoxetine for residual fatigue in major depressive disorder
416. Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review
417. Risk of Suicidality in Depression with Serotonergic Antidepressants
418. Rating Scales for Depression
419. CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT (COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANS
420. Antidepressant Effects on Emotional Temperament: Toward a Biobehavioral Research Paradigm for Major Depressive Disorder
421. EFFECT OF CONCURRENT SUBSTANCE USE DISORDER ON THE EFFECTIVENESS OF SINGLE AND COMBINATION ANTIDEPRESSANT MEDICATIONS FOR THE TREATMENT OF MAJOR DEPRESSION: AN EXPLORATORY ANALYSIS OF A SINGLE-BLIND RANDOMIZED TRIAL
422. WHAT ARE THE CLINICAL IMPLICATIONS OF NEW ONSET OR WORSENING ANXIETY DURING THE FIRST TWO WEEKS OF SSRI TREATMENT FOR DEPRESSION?
423. Mood Disorders: Major Depressive Disorder and Dysthymic Disorder
424. Diagnostic Rating Scales and Psychiatric Instruments
425. Pharmacological Approaches to Treatment-Resistant Depression
426. Preface
427. Antidepressants
428. Contributors
429. RECALLING PAINFUL MEMORIES...DEPRESSION CAUSES...SUNDOWNING
430. MONOTONY OF QUARANTINE...MOVING TO ASSISTED-LIVING FACILITY...HUNTINGTON'S DISEASE
431. MIXED DEMENTIA... CAUSES OF DELIRIUM... GRIEF VS. DEPRESSION
432. Assessing anxious features in depressed outpatients
433. Assessing depression and factors possibly associated with depression during the course of Parkinsonʼs disease
434. Association Between Bipolar Spectrum Features and Treatment Outcomes in Outpatients With Major Depressive Disorder
435. Compulsive Alcohol Use and Other High-Risk Behaviors among College Students
436. WITHDRAWN: Size Does Matter, But It Isn't Everything: The Challenge of Modest Treatment Effects in Chronic Pain Clinical Trials
437. Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults
438. Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study
439. Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse
440. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study
441. John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials
442. Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study
443. Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study
444. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women
445. Efficacy of Esketamine Augmentation in Major Depressive Disorder
446. Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia
447. Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder
448. Characterizing Cerebral Blood Perfusion and Treatment Outcomes in Atypical and Melancholic Depression
449. Neural Circuits Linking Irritability and Anger Attacks in Major Depressive Disorder: Findings From EMBARC Study
450. Cognitive Subtypes of Depression are Associated With Response to Treatment by Sertraline
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.